---
document_datetime: 2025-04-08 12:15:45
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/pavblu-epar-all-authorised-presentations_en.pdf
document_name: pavblu-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7812481
conversion_datetime: 2025-12-22 14:05:37.977512
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size            |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------|---------------------------|----------------------|
| EU/1/25/1909/001 | PAVBLU            | 40 mg/ml   | Solution for injection | Intravitreal use          | pre-filled syringe    | 0.09 ml                   | 1 pre-filled syringe |
| EU/1/25/1909/002 | PAVBLU            | 40 mg/ml   | Solution for injection | Intravitreal use          | vial (glass)          | 0.1 ml                    | 1 vial               |